Tinea incognita
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Tinea incognita | |
|---|---|
| File:Tinea incognito.jpg | |
| Synonyms | Tinea incognito |
| Pronounce | N/A |
| Specialty | Dermatology |
| Symptoms | Atypical skin lesions, often with less inflammation |
| Complications | Misdiagnosis, prolonged infection |
| Onset | Varies |
| Duration | Chronic if untreated |
| Types | N/A |
| Causes | Dermatophyte infection modified by topical steroid use |
| Risks | Use of topical steroids, immunosuppression |
| Diagnosis | KOH test, Fungal culture, Skin biopsy |
| Differential diagnosis | Eczema, Psoriasis, Contact dermatitis |
| Prevention | Avoid inappropriate use of topical steroids |
| Treatment | Antifungal medications |
| Medication | Terbinafine, Itraconazole, Fluconazole |
| Prognosis | Good with appropriate treatment |
| Frequency | Common in cases of misdiagnosed fungal infections |
| Deaths | N/A |
Tinea incognita is a dermatological condition characterized by a fungal infection that presents atypically due to the use of topical immunosuppressive agents, such as corticosteroids. This condition is often misdiagnosed because the typical inflammatory response is suppressed, leading to a less obvious clinical presentation.
Pathophysiology[edit]
Tinea incognita occurs when a dermatophyte infection is altered by the application of topical corticosteroids or other immunosuppressive treatments. These agents reduce the body's inflammatory response, which can mask the typical signs of a fungal infection, such as redness, scaling, and itching. As a result, the infection may spread more extensively before being correctly identified.
Clinical Presentation[edit]
The clinical presentation of tinea incognita can vary significantly, making diagnosis challenging. Common features include:
- Atypical Lesions: The lesions may appear less inflamed and more subtle than typical tinea infections.
- Color Changes: The affected skin may show unusual pigmentation, often appearing hypopigmented or hyperpigmented.
- Minimal Scaling: Unlike classic tinea infections, scaling may be minimal or absent.
- Widespread Distribution: The infection may cover a larger area due to delayed diagnosis and treatment.
Diagnosis[edit]
Diagnosis of tinea incognita requires a high index of suspicion, especially in patients with a history of topical steroid use. Diagnostic methods include:
- KOH Preparation: A potassium hydroxide (KOH) preparation of skin scrapings can reveal fungal elements.
- Fungal Culture: Culturing the organism can confirm the diagnosis and identify the specific dermatophyte.
- Skin Biopsy: In some cases, a skin biopsy may be necessary to differentiate from other dermatoses.
Treatment[edit]
The primary treatment for tinea incognita involves discontinuing the use of topical corticosteroids and initiating antifungal therapy. Options include:
- Topical Antifungals: Such as clotrimazole or terbinafine.
- Oral Antifungals: In extensive cases, oral antifungals like itraconazole or fluconazole may be required.
Prevention[edit]
Preventing tinea incognita involves careful use of topical corticosteroids, particularly in patients with a history of fungal infections. Educating patients about the potential risks of self-medicating with steroids is crucial.
